SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Gramz Mark A (Last) (First) (Middle) 100 EAST WISCONSIN AVENUE SUITE 1900 (Street) MILWAUKEE WI 53202-4125 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 05/31/2023	3. Issuer Name and Ticker or Trading Symbol MARCUS CORP [ MCS ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Pres., Marcus Theatres Corp*	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,271	D
Common Stock	6,700(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	07/29/2024	Common Stock	700	$18.34	D
Stock Option (Right to Buy)	(2)	07/28/2025	Common Stock	3,500	$20.26	D
Stock Option (Right to Buy)	(2)	02/28/2026	Common Stock	2,040	$18.68	D
Stock Option (Right to Buy)	(2)	02/28/2027	Common Stock	3,500	$31.2	D
Stock Option (Right to Buy)	(3)	02/27/2028	Common Stock	3,500	$27	D
Stock Option (Right to Buy)	(3)	02/26/2029	Common Stock	3,500	$41.9	D
Stock Option (Right to Buy)	(3)	02/25/2030	Common Stock	3,500	$28.88	D
Stock Option (Right to Buy)	(3)	05/08/2030	Common Stock	1,750	$12.71	D
Stock Option (Right to Buy)	(3)	03/09/2031	Common Stock	4,200	$21.84	D
Stock Option (Right to Buy)	(3)	03/08/2032	Common Stock	3,500	$17.04	D
Stock Option (Right to Buy)	(3)	03/07/2033	Common Stock	27,500	$15.99	D

Explanation of Responses:

1. Restricted stock granted March 1, 2023 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.

2. The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.

3. The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.

Remarks:

President, Marcus Theatres Corporation*

	/s/ Steven R. Barth, Attorney-in-Fact for Mark A. Gramz	08/14/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.